Lv6
2780 积分 2024-09-06 加入
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
1个月前
已完结
新药非临床研究一般考虑及案例分析
3个月前
已完结
PD-1_PD-L1抗体临床前药效标志物和CAR-T细胞临床前药效评价的特点及检测方法
3个月前
已完结
US Food and Drug Administration Approval Summary: Inavolisib With Palbociclib and Fulvestrant for Endocrine-Resistant, PIK3CA -Mutated, Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, Locally Advanced or Metastatic Breast Cancer
4个月前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
4个月前
已完结
CAR T cell–mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis
4个月前
已完结
CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours
4个月前
已完结
Safety and Efficacy of Autologous RNA Chimeric Antigen Receptor T-cell (rCAR-T) Therapy in Myasthenia Gravis: a prospective, multicenter, open-label, non-randomised phase 1b/2a study
6个月前
已完结
Chimeric antigen receptors of HBV envelope proteins inhibit hepatitis B surface antigen secretion
6个月前
已完结
A single infusion of engineered long-lived and multifunctional T cells confers durable remission of asthma in mice
6个月前
已完结
皖公网安备34019202002308
